.jpg)
.png)
All
We report the case of a young girl who presented with classic type III hyperlipoproteinemia to emphasize the importance of clarifying the lipid diagnoses, to illustrate the key features of this uncommon condition, and to demonstrate the potency of non-pharmacologic therapy in improving both... more
David Capuzzi, MD, PhD, FNLA currently works with the cardiology group at the Lankenau Medical Center (Main Line Health) as an advisor to the cardiovascular disease prevention program, where he participates in clinical research and the cardiology fellows training program. Dr. Capuzzi values this... more
American Diabetes Association The American Diabetes Association is the leader in the fight against the deadly consequences of diabetes and those affected by diabetes. Their mission includes funding research to prevent, cure and manage diabetes, delivering services to hundreds of communities... more
Are you active on Twitter? If so, the NLA (@nationallipid) would like to invite you to join us on Wednesday, September 23 at 7 pm ET, for our first ever #NLAchat! The topic for our #NLAchat is: "The Effect of Diet and Physical Activity on Cholesterol." The NLA (@... more
Overview Meet WHG News Articles Resources Contact WHG Women's Health Articles Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study Statin Use in Women: Unique Aspects over the Lifespan Contemporary... more
A decade ago, the lipid community was eagerly awaiting the completion of Phase III trials of torcetrapib, the first- in-class of the cholesteryl ester transfer protein (CETP) inhibitors. Given the epidemiological assumptions that every 1.0 mg/dL increase in high-density lipoprotein cholesterol... more
The National Lipid Association recently convened an Expert Panel to draft a document that would serve as guidance to clinicians for treating patients with dyslipidemia. Our foremost goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American Heart... more
Regeneron Pharmaceuticals, Inc. announced positive results from a Phase 3 trial evaluating Evkeeza® (evinacumab) in children aged 5 to 11 with homozygous familial hypercholesterolemia (HoFH). The trial met its primary endpoint, showing children who added... more
Physical chemistry is, in part, the study of macroscopic and particulate phenomena in terms of laws and concepts of physics, and it can include the physical concepts determining motion, energy, force, time, thermodynamics, light and equilibrium. Physical chemistry, in contrast to chemical physics,... more